PMID- 15534563 OWN - NLM STAT- MEDLINE DCOM- 20050105 LR - 20211203 IS - 1462-0308 (Print) IS - 1462-0308 (Linking) VI - 9 IP - 3 DP - 2004 Sep TI - HIV and human leukocyte antigen association--the Indian scenario. PG - 60-4 AB - Genetic factors such as human leukocyte antigen (HLA) affect the infection and progression of HIV disease. The dependence of effective cytotoxic T lymphocyte (CTL) activity on HIV-specific T-helper responses has become increasingly evident and studies provide strong evidence that T-helper responses and the magnitude of CTL responses are closely linked. HLA haplotype A11-B35-Cw4 has been associated with rapid progression of AIDS. Our earlier studies had shown that HLA B*3520, B*1801 and Cw*1507 alleles were associated in western Indian HIV-1-infected AIDS patients. Further, it was observed that A*110101-B*3520-Cw*1507 haplotype was significantly increased among the AIDS patients. I compiled the frequency of these alleles and their molecular subtype distribution from 4333 individuals from India. The results showed that these high-risk alleles and their subtypes were significantly increased among selected castes or population groups (breeding isolates living in the plains) but lower in tribal groups (breeding isolates living in the hills), which revealed a high genetic diversity among Indians. My analysis shows that the genetic susceptibility and HLA allelic immune response among the HIV-infected AIDS individuals in India are different. FAU - Shankarkumar, Umapathy AU - Shankarkumar U AD - HLA Department, Institute of Immunohaematology (ICMR), 13th Floor, KEM Hospital, Parel, Mumbai 400 012, India. LA - eng PT - Journal Article PT - Review PL - England TA - J HIV Ther JT - Journal of HIV therapy JID - 101088049 RN - 0 (HLA Antigens) SB - IM MH - Alleles MH - Disease Susceptibility MH - Ethnicity MH - Genetic Variation/immunology MH - HIV Infections/*genetics/*immunology MH - HIV-1/*immunology MH - HLA Antigens/*genetics/*immunology MH - Haplotypes/genetics MH - Humans MH - India RF - 21 EDAT- 2004/11/10 09:00 MHDA- 2005/01/06 09:00 CRDT- 2004/11/10 09:00 PHST- 2004/11/10 09:00 [pubmed] PHST- 2005/01/06 09:00 [medline] PHST- 2004/11/10 09:00 [entrez] PST - ppublish SO - J HIV Ther. 2004 Sep;9(3):60-4.